Gyrus Capital to acquire LivaNova’s heart valve business
The divestment of the HV business will help LivaNova to focus more on its neuromodulation and cardiovascular segments
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Dec 20
The divestment of the HV business will help LivaNova to focus more on its neuromodulation and cardiovascular segments
04 Dec 20
As Access Bio’s exclusive US commercialization partner, Intrivo’s new channel agreements will expand the supply chain for the…
04 Dec 20
The test kit uses saliva as sample, which is shipped to the laboratory in a pre-paid shipping container
04 Dec 20
Caretaker wireless patient monitor offers touchless, clinically distanced, continuous blood pressure and ICU quality vital signs
04 Dec 20
Minerva Surgical delivers one complete suite of devices that treat the root causes of Abnormal Uterine Bleeding (AUB)
04 Dec 20
With unprecedented sample volumes expected, this flu season poses critical testing challenges for laboratories, which must reliably and…
04 Dec 20
Hardware as a Service solution allows secure temperature and mask checks for safer workspace reopening
New dilation balloon can be inflated in three steps, eliminating the need for multiple balloons in the same…
03 Dec 20
The Covid-19 vaccine from Pfizer may signal hope for an end to the pandemic, but the company's rich…
03 Dec 20
The device aims to give clarity to parents on whether kids are wheezing, allowing them to act in…